Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

AFC-HD AMS Life Science Co stock

2927.T
JP3124700000

Price

831.00
Today +/-
+0
Today %
+0 %
P

AFC-HD AMS Life Science Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the AFC-HD AMS Life Science Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the AFC-HD AMS Life Science Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the AFC-HD AMS Life Science Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze AFC-HD AMS Life Science Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

AFC-HD AMS Life Science Co Stock Price History

DateAFC-HD AMS Life Science Co Price
11/14/2024831.00 undefined
11/13/2024831.00 undefined
11/12/2024827.00 undefined
11/11/2024833.00 undefined
11/8/2024835.00 undefined
11/7/2024829.00 undefined
11/6/2024830.00 undefined
11/5/2024828.00 undefined
11/1/2024829.00 undefined
10/31/2024835.00 undefined
10/30/2024832.00 undefined
10/29/2024833.00 undefined
10/28/2024827.00 undefined
10/25/2024823.00 undefined
10/24/2024832.00 undefined
10/23/2024835.00 undefined
10/22/2024844.00 undefined
10/21/2024853.00 undefined
10/18/2024850.00 undefined
10/17/2024850.00 undefined

AFC-HD AMS Life Science Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into AFC-HD AMS Life Science Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by AFC-HD AMS Life Science Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects AFC-HD AMS Life Science Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of AFC-HD AMS Life Science Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into AFC-HD AMS Life Science Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing AFC-HD AMS Life Science Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on AFC-HD AMS Life Science Co’s growth potential.

AFC-HD AMS Life Science Co Revenue, EBIT and net profit per share

DateAFC-HD AMS Life Science Co RevenueAFC-HD AMS Life Science Co EBITAFC-HD AMS Life Science Co Net Income
202430.19 B undefined1.92 B undefined1.24 B undefined
202325.58 B undefined1.64 B undefined1.1 B undefined
202223.02 B undefined1.02 B undefined735.35 M undefined
202122.37 B undefined2.25 B undefined1.5 B undefined
202015.82 B undefined1.09 B undefined676.68 M undefined
201916.25 B undefined981.83 M undefined783.29 M undefined
201815.8 B undefined1.02 B undefined736.68 M undefined
201715.14 B undefined1.07 B undefined465.89 M undefined
201614.63 B undefined891.4 M undefined489.6 M undefined
201514.42 B undefined951.76 M undefined605.5 M undefined
201413.73 B undefined565 M undefined283 M undefined
201314.37 B undefined903 M undefined572 M undefined
201214.8 B undefined727 M undefined569 M undefined
201114.65 B undefined1.06 B undefined490 M undefined
201014.45 B undefined818 M undefined195 M undefined
200912.81 B undefined775 M undefined130 M undefined
200810.22 B undefined887 M undefined355 M undefined
20076.95 B undefined653 M undefined485 M undefined
20065.46 B undefined483 M undefined287 M undefined
20055.96 B undefined984 M undefined523 M undefined

AFC-HD AMS Life Science Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
3.274.345.965.466.9510.2212.8114.4514.6514.814.3713.7314.4214.6315.1415.816.2515.8222.3723.0225.5830.19
-32.6437.36-8.3327.3347.0425.3512.771.420.96-2.90-4.445.001.503.494.322.89-2.6641.402.9311.1018.01
52.3153.6451.5848.5047.3040.2638.3736.0136.7632.0530.8829.9529.5530.0030.4329.0727.8128.7930.6937.2736.4434.76
1.712.333.072.653.294.124.925.25.394.744.444.114.264.394.614.594.524.556.878.589.3210.49
0.080.310.520.290.490.360.130.20.490.570.570.280.610.490.470.740.780.681.50.741.11.24
-282.5070.92-45.1268.99-26.80-63.3850.00151.2816.120.53-50.52113.78-19.17-4.9158.286.39-13.67121.15-50.8449.9312.89
----------------------
----------------------
11111113131312121212121212.1112.1412.1112.6414.0614.0614.0714.1214.0514.05
----------------------
Details

Keystats

ⓘ

Revenue and Growth

The AFC-HD AMS Life Science Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the AFC-HD AMS Life Science Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                           
0.851.161.91.511.782.243.122.863.764.054.474.124.043.723.394.084.444.739.2210.3811.1812.17
0.450.560.760.691.51.871.841.942.171.991.781.682.081.882.042.052.132.132.182.382.592.52
0000000000000000000183.25238.72296.78
0.430.520.780.641.251.341.581.721.882.072.082.092.442.392.562.812.8233.853.734.365.82
0.070.10.140.190.540.40.330.250.440.220.190.230.40.240.320.190.240.160.590.461.51.13
1.82.343.583.035.075.856.876.778.258.338.528.128.968.238.319.129.6310.0115.8517.1319.8821.93
2.212.643.73.824.454.865.466.348.938.368.298.017.817.617.978.067.867.6616.0115.9217.1419.6
0.050.060.031.261.230.880.360.330.360.550.520.520.330.30.310.620.560.60.740.850.540.59
0000000000000000000000
20112836425444294666534047.2190.9100.0193.24147.6162.78160.96118.0891.94167.14
0.020.020.020.010.060.360.320.190.110.030.010.010.01000001.491.341.292.3
0.180.190.20.20.20.30.220.190.240.150.130.120.110.110.080.10.130.121.51.992.132.41
2.472.913.975.335.986.466.417.099.699.1598.78.38.118.458.898.78.5419.920.2221.225.07
4.275.257.548.3611.0512.313.2813.8617.9417.4717.5116.8117.2716.3416.7618.0118.3318.5535.7537.3541.0747.01
                                           
0.50.51.381.391.41.41.411.411.411.411.411.411.411.411.412.132.132.132.132.132.132.13
0.110.111.461.471.481.481.481.481.481.481.481.481.471.471.472.22.22.22.442.642.642.65
0.911.211.711.852.212.432.382.462.833.223.673.94.314.574.865.415.916.247.517.918.599.44
0000000000000000-5.0516.2124.5668.1782.6165.56
-3-103228-126-66-55-61-59-8144.62-15.74-8.84-27.32-67.43-59.68-46.94-0.8119.44-62.5
1.521.824.554.745.125.195.25.295.666.056.556.87.197.437.729.7110.1710.5212.0612.7413.4614.23
0.450.650.840.660.861.291.411.521.761.611.571.652.21.821.882.011.812.012.973.413.273.59
4157856810710611011912595969393.7109.2136.5149.9171170.1196.73152.51170.09188.96
0.250.470.670.390.670.810.610.951.170.861.140.981.171.031.141.151.321.163.652.63.164.09
0.180.150022.282.272.732.873.012.992.992.292.292.732.552.762.763.966.827.919.02
0.210.190.3000.260.420.450.671.490.940.921.050.751.860.380.830.11.030.240.350.52
1.121.521.891.113.644.744.835.786.597.066.746.636.8167.756.246.96.211.813.2214.8517.4
1.351.620.82.212.011.892.862.464.473.223.12.342.651.930.511.320.491.089.7810.1811.3313.29
000004835343987127131116.5783.5187.821.0618.2115.21298.57265.55258.69238.67
0.270.290.30.30.490.490.510.51.381.261.221.140.60.950.760.780.820.781.211.241.482.1
1.631.911.12.512.492.423.42.995.894.564.453.613.372.971.352.111.321.8811.2911.6813.0615.63
2.753.432.993.626.137.168.238.7712.4811.6211.1910.2410.188.979.18.358.228.0823.0924.927.9133.03
4.275.257.548.3611.2512.3513.4314.0618.1417.6717.7417.0417.3716.416.8218.0718.3918.6135.1537.6541.3847.26
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of AFC-HD AMS Life Science Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand AFC-HD AMS Life Science Co's financial health and stability.

Assets

AFC-HD AMS Life Science Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that AFC-HD AMS Life Science Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of AFC-HD AMS Life Science Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into AFC-HD AMS Life Science Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.150.570.920.480.870.810.420.680.930.970.980.490.960.760.640.991.0912.161.241.55
0.110.10.120.240.230.280.410.430.360.730.60.510.440.40.380.440.470.510.651.010.98
000000000000000000000
-103-139-725-390-661-98-542-193-989-12127-136-620-489-966-247-366-363-287-512-1,767
1436416626-76145394199208-200-25278219247147-6514863-237102
3838443495579737199125111947864563428315858
11571401469185451383221611441161431140383256180263381321993282
0.30.60.470.360.361.130.681.120.511.381.580.890.860.850.531.221.131.32.581.490.87
-79-472-1,053-550-639-325-900-1,295-1,837-435-540-229-257-163-851-549-546-381-492-957-1,939
11-471-1,033-1,746-1,599-196-726-1,308-1,975-508-350-260-86-220-846-850-202-458-274-1,077-1,946
90119-1,195-960128174-12-137-73189-31171-565-300344-77217-119-6
000000000000000000000
-0.090.22-0.861.11.8-0.571.110.082.37-0.3-0.68-0.78-0.65-0.630.13-0.85-0.17-0.132.712.452.4
0.102.20.01-0.180.14-0.1-0.0500-0.0300001.4400-0.15-0.29-0.08
-0.010.21.310.961.5-0.540.84-0.082.25-0.47-0.83-1.07-0.91-0.99-0.050.28-0.55-0.572.191.161.88
00-14-40000000-108-135-1769-128-95-93-58-583-52
-15-16-22-137-118-119-180-118-118-177-119-177-118-180-181-180-280-350-312-421-385
0.30.330.75-0.430.250.390.79-0.270.790.390.4-0.44-0.14-0.35-0.370.650.380.274.51.590.8
217.5124.1-579.5-194.8-281.7804.3-216.9-174.5-1,325.59401,035.9663.7599.19691.17-326.33672.3585.14917.742,090.62534.45-1,074.4
000000000000000000000

AFC-HD AMS Life Science Co stock margins

The AFC-HD AMS Life Science Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of AFC-HD AMS Life Science Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for AFC-HD AMS Life Science Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the AFC-HD AMS Life Science Co's sales revenue. A higher gross margin percentage indicates that the AFC-HD AMS Life Science Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the AFC-HD AMS Life Science Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the AFC-HD AMS Life Science Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the AFC-HD AMS Life Science Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the AFC-HD AMS Life Science Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the AFC-HD AMS Life Science Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

AFC-HD AMS Life Science Co Margin History

AFC-HD AMS Life Science Co Gross marginAFC-HD AMS Life Science Co Profit marginAFC-HD AMS Life Science Co EBIT marginAFC-HD AMS Life Science Co Profit margin
202434.76 %6.36 %4.12 %
202336.45 %6.4 %4.31 %
202237.28 %4.41 %3.19 %
202130.69 %10.04 %6.69 %
202028.79 %6.92 %4.28 %
201927.82 %6.04 %4.82 %
201829.08 %6.48 %4.66 %
201730.43 %7.07 %3.08 %
201630 %6.09 %3.35 %
201529.56 %6.6 %4.2 %
201429.95 %4.12 %2.06 %
201330.88 %6.29 %3.98 %
201232.05 %4.91 %3.85 %
201136.76 %7.25 %3.34 %
201036.01 %5.66 %1.35 %
200938.37 %6.05 %1.01 %
200840.26 %8.68 %3.47 %
200747.3 %9.39 %6.98 %
200648.5 %8.85 %5.26 %
200551.58 %16.52 %8.78 %

AFC-HD AMS Life Science Co Stock Sales Revenue, EBIT, Earnings per Share

The AFC-HD AMS Life Science Co earnings per share therefore indicates how much revenue AFC-HD AMS Life Science Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue AFC-HD AMS Life Science Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates AFC-HD AMS Life Science Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of AFC-HD AMS Life Science Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating AFC-HD AMS Life Science Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

AFC-HD AMS Life Science Co Revenue, EBIT and net profit per share

DateAFC-HD AMS Life Science Co Sales per ShareAFC-HD AMS Life Science Co EBIT per shareAFC-HD AMS Life Science Co Earnings per Share
20242,147.92 undefined136.56 undefined88.54 undefined
20231,820.24 undefined116.44 undefined78.46 undefined
20221,630.69 undefined71.89 undefined52.08 undefined
20211,589.84 undefined159.66 undefined106.3 undefined
20201,124.83 undefined77.81 undefined48.12 undefined
20191,155.66 undefined69.81 undefined55.7 undefined
20181,249.68 undefined81.02 undefined58.28 undefined
20171,250.48 undefined88.35 undefined38.48 undefined
20161,205.45 undefined73.44 undefined40.34 undefined
20151,190.25 undefined78.59 undefined50 undefined
20141,144 undefined47.08 undefined23.58 undefined
20131,197.17 undefined75.25 undefined47.67 undefined
20121,232.92 undefined60.58 undefined47.42 undefined
20111,221.17 undefined88.5 undefined40.83 undefined
20101,204.08 undefined68.17 undefined16.25 undefined
20091,067.75 undefined64.58 undefined10.83 undefined
2008786.31 undefined68.23 undefined27.31 undefined
2007534.77 undefined50.23 undefined37.31 undefined
2006420 undefined37.15 undefined22.08 undefined
2005541.45 undefined89.45 undefined47.55 undefined

AFC-HD AMS Life Science Co business model

AFC-HD AMS Life Science Co is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

AFC-HD AMS Life Science Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

AFC-HD AMS Life Science Co historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

AFC-HD AMS Life Science Co shares outstanding

The number of shares was AFC-HD AMS Life Science Co in 2023 — This indicates how many shares 14.053 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue AFC-HD AMS Life Science Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates AFC-HD AMS Life Science Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of AFC-HD AMS Life Science Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating AFC-HD AMS Life Science Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

AFC-HD AMS Life Science Co stock splits

In AFC-HD AMS Life Science Co's history, there have been no stock splits.

AFC-HD AMS Life Science Co dividend history and estimates

In 2023, AFC-HD AMS Life Science Co paid a dividend amounting to 27.5 JPY. Dividend means that AFC-HD AMS Life Science Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for AFC-HD AMS Life Science Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify AFC-HD AMS Life Science Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating AFC-HD AMS Life Science Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

AFC-HD AMS Life Science Co Dividend History

DateAFC-HD AMS Life Science Co Dividend
202430 undefined
202327.5 undefined
202230 undefined
202127.5 undefined
202020 undefined
201920 undefined
201820 undefined
201710 undefined
201610 undefined
201510 undefined
201410 undefined
201310 undefined
201210 undefined
201110 undefined
201010 undefined
200910 undefined
200810 undefined
200710 undefined
200615 undefined
20056.67 undefined

AFC-HD AMS Life Science Co dividend payout ratio

In 2023, AFC-HD AMS Life Science Co had a payout ratio of 41.68%. The payout ratio indicates the percentage of the company's profits that AFC-HD AMS Life Science Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for AFC-HD AMS Life Science Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for AFC-HD AMS Life Science Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate AFC-HD AMS Life Science Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

AFC-HD AMS Life Science Co Payout Ratio History

DateAFC-HD AMS Life Science Co Payout ratio
202441.72 %
202341.68 %
202257.6 %
202125.87 %
202041.57 %
201935.91 %
201834.32 %
201725.99 %
201624.79 %
201520 %
201442.41 %
201320.98 %
201221.09 %
201124.49 %
201061.54 %
200992.34 %
200836.63 %
200726.81 %
200667.97 %
200514.02 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for AFC-HD AMS Life Science Co.

AFC-HD AMS Life Science Co shareholders

%
Name
Stocks
Change
Date
14.84356 % Asayama (Tadahiko)2,087,57037,5002/29/2024
8.40406 % Asayama (Takehiko)1,181,93020,0002/29/2024
2.88471 % AFC-HD AMS Life Science Co., Ltd. Customers405,70018,1002/29/2024
2.78730 % Kinoshita (Keiichiro)392,00055,3002/29/2024
2.20424 % Asayama (Maiko)310,0005,0002/29/2024
2.13314 % Asayama (Marina)300,00002/29/2024
0.93005 % JPMorgan Securities Japan Co., Ltd.130,80016,2002/29/2024
0.91844 % Fujita (Keisuke)129,16702/29/2024
0.88810 % The Shizuoka Bank, Ltd.124,90002/29/2024
0.67976 % Dimensional Fund Advisors, L.P.95,6007,8007/31/2024
1
2

Most common questions regarding AFC-HD AMS Life Science Co

What is the P/E ratio of AFC-HD AMS Life Science Co 2024?

The AFC-HD AMS Life Science Co P/E ratio is 9.39.

What is the P/S ratio of AFC-HD AMS Life Science Co 2024?

The AFC-HD AMS Life Science Co P/S ratio is 0.39.

What is the Quality Investing of AFC-HD AMS Life Science Co?

The Quality Investing for AFC-HD AMS Life Science Co is 4/10.

What is the revenue of AFC-HD AMS Life Science Co 2024?

The AFC-HD AMS Life Science Co revenue is 30.19 B JPY.

How high is the profit of AFC-HD AMS Life Science Co 2024?

The AFC-HD AMS Life Science Co profit is 1.24 B JPY.

What is the business model of AFC-HD AMS Life Science Co

No history available for AFC-HD AMS Life Science Co.

What is the AFC-HD AMS Life Science Co dividend?

AFC-HD AMS Life Science Co pays a dividend of 30 JPY distributed over payouts per year.

How often does AFC-HD AMS Life Science Co pay dividends?

The dividend cannot currently be calculated for AFC-HD AMS Life Science Co or the company does not pay out a dividend.

What is the AFC-HD AMS Life Science Co ISIN?

The ISIN of AFC-HD AMS Life Science Co is JP3124700000.

What is the AFC-HD AMS Life Science Co ticker?

The ticker of AFC-HD AMS Life Science Co is 2927.T.

How much dividend does AFC-HD AMS Life Science Co pay?

Over the past 12 months, AFC-HD AMS Life Science Co paid a dividend of 30 JPY . This corresponds to a dividend yield of about 3.61 %. For the coming 12 months, AFC-HD AMS Life Science Co is expected to pay a dividend of 30 JPY.

What is the dividend yield of AFC-HD AMS Life Science Co?

The current dividend yield of AFC-HD AMS Life Science Co is 3.61 %.

When does AFC-HD AMS Life Science Co pay dividends?

AFC-HD AMS Life Science Co pays a quarterly dividend. This is distributed in the months of March, September, March, September.

How secure is the dividend of AFC-HD AMS Life Science Co?

AFC-HD AMS Life Science Co paid dividends every year for the past 20 years.

What is the dividend of AFC-HD AMS Life Science Co?

For the upcoming 12 months, dividends amounting to 30 JPY are expected. This corresponds to a dividend yield of 3.61 %.

In which sector is AFC-HD AMS Life Science Co located?

AFC-HD AMS Life Science Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von AFC-HD AMS Life Science Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AFC-HD AMS Life Science Co from 11/1/2024 amounting to 15 JPY, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.

When did AFC-HD AMS Life Science Co pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of AFC-HD AMS Life Science Co in the year 2023?

In the year 2023, AFC-HD AMS Life Science Co distributed 27.5 JPY as dividends.

In which currency does AFC-HD AMS Life Science Co pay out the dividend?

The dividends of AFC-HD AMS Life Science Co are distributed in JPY.

All fundamentals about AFC-HD AMS Life Science Co

Our stock analysis for AFC-HD AMS Life Science Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AFC-HD AMS Life Science Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.